STAT3 and primary biliary cholangitis: To determine the correlation of the unchanged STAT3 activation with resveratrol insensitivity of human GM cells, 60 μM AG490, a selective inhibitor of STAT3 phosphorylation, was used to treat LN-18, UW228-3 and PBC cells, respectively.